Literature DB >> 31346989

Diagnostic and Prognostic Value of Plasma Factor V Activity and Parameters in Thrombin Generation for Disseminated Intravascular Coagulation in Patients with Hematological Malignancies.

Hai-Ming Kou1,2, Xiao-Ping Zhang1,2, Man-Zhi Wang1,2, Jun Deng1,2, Heng Mei1,2, Yu Hu3,4.   

Abstract

In this study, we used plasma factor V activity and parameters of the thrombin generation test to discuss their diagnostic and prognostic value for disseminated intravascular coagulation (DIC) in patients with hematological malignancies. A total of 164 patients who were diagnosed with hematological malignancies in the Department of Hematology, Union Hospital, between Apr. 2014 and Dec. 2014 were enrolled in this study. There were 131 patients in the study group and 33 patients in the control group in terms of the laboratory results for DIC. The patients in the study group were divided into a DIC subgroup (n=59) and a non-DIC subgroup (n=72) based on the International Society of Thrombosis and Hemostasis (ISTH) Integral System, and they were divided into four subgroups [score ≤3 (n=35), score=4 (n=37), score=5 (n=47), and score ≥6 (n=12)] according to ISTH scores. Using 28-day mortality as the endpoint, the patients in the study group were divided into a survival subgroup (n=111) and a non-survival subgroup (n=20). The results showed that the plasma factor V activity was significantly weaker, and lag time and time to peak were significantly shorter in the study group than in the control group (P<0.01). The factor V activity, peak and endogenous thrombin potential (ETP) were significantly decreased in the DIC subgroup as compared with those in the non-DIC subgroup (P<0.01). Among factor V activity, lag time, peak, ETP, and ttPeak, only the factor V activity was significantly decreased in the non-survival subgroup compared with the survival subgroup (P<0.01). With the increase in ISTH score, the ETP and peak decreased gradually. The binary logistic regression analysis revealed that PLT, D-dimer, factor V activity and ETP had linear relationship with DIC diagnosed by ISTH Integral System. Using DIC diagnosed by ISTH Integral System as the endpoint, the area under curve (AUC) of factor V activity was found to be similar to that of blood platelet count (PLT) and prothrombin time (PT). In conclusion, factor V activity, ETP and peak had diagnostic value for DIC in patients with hematological malignancies, and only factor V activity had limited prognostic value.

Entities:  

Keywords:  disseminated intravascular coagulation; factor V activity; hematological malignancies; thrombin generation test

Mesh:

Substances:

Year:  2019        PMID: 31346989     DOI: 10.1007/s11596-019-2072-9

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  12 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.

Authors:  Ji-Weon Seo; Hyun Kyung Kim; Ji-Eun Kim; Seonyang Park; Han-Ik Cho
Journal:  Thromb Res       Date:  2008-05-13       Impact factor: 3.944

3.  Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation.

Authors:  Kamran Bakhtiari; Joost C M Meijers; Evert de Jonge; Marcel Levi
Journal:  Crit Care Med       Date:  2004-12       Impact factor: 7.598

4.  Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome.

Authors:  C Solano; M Lamuño; A Vargas; L M Amezcua-Guerra
Journal:  Clin Exp Rheumatol       Date:  2009 Nov-Dec       Impact factor: 4.473

5.  Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan.

Authors:  N Kobayashi; T Maekawa; M Takada; H Tanaka; H Gonmori
Journal:  Bibl Haematol       Date:  1983

Review 6.  Disseminated intravascular coagulation: a review for the internist.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Intern Emerg Med       Date:  2012-09-27       Impact factor: 3.397

7.  Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure.

Authors:  S Izumi; P G Langley; J Wendon; A J Ellis; R B Pernambuco; R D Hughes; R Williams
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

8.  Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation.

Authors:  Takemitsu Takemitsu; Hideo Wada; Tsuyoshi Hatada; Yukinari Ohmori; Ken Ishikura; Taichi Takeda; Takashi Sugiyama; Norikazu Yamada; Kazuo Maruyama; Naoyuki Katayama; Shiji Isaji; Hideto Shimpo; Masato Kusunoki; Tsutomu Nobori
Journal:  Thromb Haemost       Date:  2010-10-12       Impact factor: 5.249

9.  Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.

Authors:  H Wada; Y Wakita; T Nakase; M Shimura; K Hiyoyama; S Nagaya; Y Mori; H Shiku
Journal:  Thromb Haemost       Date:  1995-09       Impact factor: 5.249

10.  A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.

Authors:  Satoshi Gando; Toshiaki Iba; Yutaka Eguchi; Yasuhiro Ohtomo; Kohji Okamoto; Kazuhide Koseki; Toshihiko Mayumi; Atsuo Murata; Toshiaki Ikeda; Hiroyasu Ishikura; Masashi Ueyama; Hiroshi Ogura; Shigeki Kushimoto; Daizoh Saitoh; Shigeatsu Endo; Shuji Shimazaki
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.